000 | 01249 a2200337 4500 | ||
---|---|---|---|
005 | 20250517034004.0 | ||
264 | 0 | _c20151016 | |
008 | 201510s 0 0 eng d | ||
022 | _a1699-3993 | ||
024 | 7 |
_a10.1358/dot.2015.51.4.2291051 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aDahl, J | |
245 | 0 | 0 |
_aBlinatumomab for the treatment of adult acute lymphoblastic leukemia. _h[electronic resource] |
260 |
_bDrugs of today (Barcelona, Spain : 1998) _cApr 2015 |
||
300 |
_a231-41 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aAntibodies, Bispecific _xadministration & dosage |
650 | 0 | 4 |
_aAntigens, CD19 _ximmunology |
650 | 0 | 4 |
_aAntigens, Neoplasm _ximmunology |
650 | 0 | 4 |
_aAntineoplastic Agents _xadministration & dosage |
650 | 0 | 4 | _aClinical Trials as Topic |
650 | 0 | 4 | _aDisease-Free Survival |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aPrecursor Cell Lymphoblastic Leukemia-Lymphoma _xdrug therapy |
700 | 1 | _aMace, M | |
700 | 1 | _aKantarjian, H | |
700 | 1 | _aJabbour, E | |
773 | 0 |
_tDrugs of today (Barcelona, Spain : 1998) _gvol. 51 _gno. 4 _gp. 231-41 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1358/dot.2015.51.4.2291051 _zAvailable from publisher's website |
999 |
_c24942484 _d24942484 |